Bioceramic Medical Devices Enter a New Phase
Bioceramic medical devices are implantable components made from biologically compatible ceramic materials that are engineered to interact safely with human tissue, support bone growth, and withstand long-term physiological loads while being produced with advanced processes such as 3D printing for customized, patient-specific treatments. In this context, calcium phosphate and hydroxyapatite ceramics are attracting attention because they resemble the mineral phase of natural bone, helping 3D printed implants integrate instead of remaining passive fillers. Himed, a long‑standing provider of these materials, has formed a partnership with Adva Cera, a ceramic 3D printing service using Lithoz and Prodways Ceram equipment, to move from “idea to implant.” Their focus on spine, orthopedic, and dental 3D printed implants shows how biocompatible ceramics and additive manufacturing are converging into a distinct class of devices that aim to bond with bone rather than merely coexist beside it.
Inside the Himed–Adva Cera Bioceramic Partnership
The collaboration brings together Himed’s Bioceramics Center of Excellence and Adva Cera’s serial ceramic 3D printing capabilities into a single pipeline for bioceramic medical devices. Himed supplies expertise in calcium phosphate and hydroxyapatite formulations, while Adva Cera handles near‑net‑shape additive production of complex ceramic parts. According to Himed President Craig Rosenblum, partnering with Adva Cera gives customers “a clear production pathway” from optimized 3D printed implant design to qualified, production‑scale ceramic additive manufacturing. Instead of building their own ceramic additive labs, device startups can concentrate on clinical concepts, funding, and commercialization, using the partnership as an outsourced engine for development and scale‑up. This asset‑light approach mirrors what some metal additive firms offer, but it is tailored to hydroxyapatite printing and related materials, where regulatory rigor, surface chemistry, and mechanical behavior must be tuned together.
Why Biocompatible Ceramics Matter for 3D Printed Implants
Ceramic 3D printing is advancing past simple shapes into implants with complex internal geometries, controlled porosity, and intricate lattice structures that can guide how tissue grows into and around the device. Himed and Adva Cera aim to produce calcium phosphate implants that bond to bone, addressing the long‑standing challenge of achieving reliable biological integration in 3D printed implants. Calcium phosphate and hydroxyapatite are already familiar to the body, aligning more closely with bone mineral than many metals or polymers used today. That opens possibilities for bone or near‑bone implants that support regenerative strategies, cell seeding, or long‑term structural repair. Matching bone’s varied strength and elasticity remains difficult, but progress in biocompatible ceramics, such as 3D printed grafts from other innovators, suggests that hydroxyapatite printing is becoming a practical route to implants that work with biology instead of against it.
From Concept to Commercialization in Additive Medicine
The Himed–Adva Cera model illustrates how material‑technology partnerships can accelerate commercialization of additive medical manufacturing without every company becoming an in‑house 3D printing expert. Adva Cera President Hugh Roberts notes that Himed has built “a center where customers can develop bioceramic technologies with the help of a highly specialized team of material scientists,” while Adva Cera is set up for serial production of advanced ceramic components. This split of responsibilities allows small, focused firms or even lone inventors to tap into a full stack of services: material science, hydroxyapatite printing process development, qualification, and scale‑ready production. As ceramics emerge as a growing segment in additive manufacturing, with more applications across medical implants, such partnerships are likely to serve as force multipliers, bringing more bioceramic medical devices, approvals, and 3D printed implants into real clinical workflows.
